⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29188044 | 0.78 | — | — | |
| SCHEMBL28317814 | 0.74 | — | — | |
| SCHEMBL22750100 | 0.68 | — | — | |
| SCHEMBL27943466 | 0.68 | — | — | |
| SCHEMBL28810624 | 0.68 | — | — | |
| SCHEMBL3976217 | 0.68 | — | — | |
| SCHEMBL3881806 | 0.65 | — | — | |
| SCHEMBL14765256 | 0.61 | — | — | |
| SCHEMBL6481913 | 0.60 | — | — | |
| Biphenyl SCHEMBL29214451 | 0.59 | SLC22A2 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2245027-A1 | HEPATITIS C VIRUS INHIBITORS | Bristol-Myers Squibb Company (US) | 2010-11-03 | — | — | EP | disclosed |
| WO-2009102633-A1 | HEPATITIS C VIRUS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-08-20 | — | — | WO | disclosed |